Reaction
Troponin I Increased reporting signals
As of the last recalculation, Troponin I Increased appears in 1,641 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is LEUCOVORIN CALCIUM (PRR 16.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Leucovorin Calcium | 25 | 16.8 | 16.9 |
| Ado-Trastuzumab Emtansine | 11 | 16.7 | 16.7 |
| Desloratadine | 12 | 14.3 | 14.3 |
| Atropine Sulfate | 12 | 14.2 | 14.2 |
| Atropine | 9 | 13.8 | 13.9 |
| Clozapine | 120 | 13.0 | 13.0 |
| Doxorubicin Hydrochloride | 31 | 12.3 | 12.3 |
| Paliperidone | 22 | 12.1 | 12.1 |
| Norepinephrine | 9 | 10.7 | 10.7 |
| Haloperidol | 20 | 10.6 | 10.6 |
| Fluorouracil | 62 | 10.5 | 10.5 |
| Fluorouracil Cream, 0.5% | 61 | 10.5 | 10.5 |
| Haloperidol Lactate | 20 | 10.4 | 10.4 |
| Colchicine | 21 | 10.2 | 10.2 |
| Doxorubicin | 67 | 9.9 | 9.9 |
| Norepinephrine Bitartrate | 11 | 9.8 | 9.8 |
| Midazolam Hydrochloride | 20 | 9.5 | 9.5 |
| Adrenalinum | 30 | 9.3 | 9.3 |
| Midazolam | 18 | 9.1 | 9.2 |
| Pembrolizumab | 72 | 9.0 | 9.0 |
| Eplerenone | 9 | 9.0 | 9.0 |
| Doxazosin | 19 | 8.7 | 8.7 |
| Rocuronium Bromide | 8 | 8.6 | 8.7 |
| Docetaxel Anhydrous | 44 | 8.5 | 8.5 |
| Docetaxel | 44 | 8.5 | 8.5 |
| Aripiprazole Oral | 27 | 8.4 | 8.4 |
| Aripiprazole Orally Disintegrating | 27 | 8.4 | 8.4 |
| Oxazepam | 14 | 8.3 | 8.3 |
| Sevoflurane | 5 | 7.7 | 7.7 |
| Trastuzumab | 40 | 7.6 | 7.6 |
| Atezolizumab | 22 | 7.3 | 7.3 |
| Ipilimumab | 24 | 7.1 | 7.1 |
| Lurasidone Hydrochloride | 11 | 6.7 | 6.7 |
| Nivolumab | 46 | 6.2 | 6.2 |
| Daratumumab | 17 | 5.4 | 5.4 |
| Tafamidis | 5 | 5.4 | 5.4 |
| Carfilzomib | 11 | 5.0 | 5.0 |
| Gemcitabine Hydrochloride | 20 | 4.8 | 4.8 |
| Azacitidine | 10 | 4.3 | 4.3 |
| Cetuximab | 10 | 4.1 | 4.1 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 3.5 | 3.5 |